Madison Wealth Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
Madison Wealth Partners's IHE Position: Q3 2026 in Review
Madison Wealth Partners increased its iShares US Pharmaceuticals ETF (IHE) stake by 0.29% in Q3 2026, buying an estimated $1.13K and bringing the position to 3,759 shares worth $378K. The position accounts for 0.04% of the portfolio, ranked #210.
Madison Wealth Partners first reported a position in IHE in Q1 2026 and has held it in 3 quarters since. 249 funds tracked by Wall St. Rank hold IHE as of Q3 2026.
- Madison Wealth Partners held 3,759 shares of iShares US Pharmaceuticals ETF worth $378K as of Q3 2026.
- Madison Wealth Partners bought 11 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $1.13K.
- iShares US Pharmaceuticals ETF made up 0.04% of Madison Wealth Partners's portfolio in Q3 2026, its #210 holding.
- Madison Wealth Partners first reported a position in iShares US Pharmaceuticals ETF in Q1 2026 and has held it in 3 quarters since.
- 249 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.
Based on Madison Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.